Quintiles logo

Quintiles

North America, North Carolina, United States, Durham

Description

Quintiles is a provider of biopharmaceutical development and commercial outsourcing services for drugs on the market.

Investor Profile

Quintiles has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (25%)
  • Series E (25%)
  • Series B (25%)
  • Series D (25%)

Country Focus

  • United States (75%)
  • Israel (25%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Therapeutics
  • Pharmaceutical
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Quintiles frequently co-invest with?

DeNovo Ventures
North America, California, United States, Saratoga
Co-Investments: 2
Pac-Link
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 2
BL
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 2
CMEA Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 2
Morgenthaler Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Latterell Venture Partners
North America, California, United States, San Francisco
Co-Investments: 2
Lilly Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 2
Pappas Ventures
North America, North Carolina, United States, Durham
Co-Investments: 2

What are some of recent deals done by Quintiles?

Bayhill Therapeutics

Portola Valley, California, United States

Bayhill Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics.

BiopharmaBiotechnologyTherapeutics
Series UnknownApr 11, 2006
Amount Raised: $15,800,000
Bayhill Therapeutics

Portola Valley, California, United States

Bayhill Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics.

BiopharmaBiotechnologyTherapeutics
Series BMay 4, 2005
Amount Raised: $35,400,000
D Pharm LTD.

Rehovot, HaMerkaz, Israel

D-Pharm is a drug-development company.

BiopharmaBiotechnologyPharmaceutical
Series DOct 16, 2001
Amount Raised: $30,000,000
NitroMed

Bedford, Massachusetts, United States

NitroMed is an emerging pharmaceutical company with substantial expertise and intellectual property in nitric oxide-based drug development.

BiotechnologyMedicalPharmaceutical
Series EJun 13, 2001
Amount Raised: $31,400,000